Giri Nam

Title: Giri Nam: Innovator in Chimeric Antigen Receptor Technology

Introduction

Giri Nam is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptors (CAR). His research focuses on enhancing the efficacy of immune cell therapies for cancer treatment.

Latest Patents

Giri Nam holds a patent for an "Immune synapse-stabilizing chimeric antigen receptor (CAR) T cell." This invention introduces a novel chimeric antigen receptor that incorporates a CD99 region, which plays a crucial role in stabilizing immune synapses. The CD99-based CAR-T cells developed from this patent demonstrate a remarkable ability to form stable immune synapses with tumor cells, surpassing the performance of conventional CAR-T cells. This advancement is expected to improve therapeutic efficiency in cancer treatments.

Career Highlights

Giri Nam is associated with Ticaros Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to enhance cancer therapies through innovative immune cell technologies.

Collaborations

Giri Nam collaborates with notable colleagues, including Kyungho Choi and Eun-Young Choi. Their combined expertise contributes to the success of their projects and the advancement of CAR technology.

Conclusion

Giri Nam's contributions to the field of immunotherapy, particularly through his patented innovations, position him as a key figure in the fight against cancer. His work exemplifies the potential of advanced technologies in improving patient outcomes.